Number of Shares
1.60 Mil
Current Holdings Value*
$20.13 Mil
% of Portfolio
1.51%
Total Estimate Gain
$8.38 Mil
% of Total Estimate Gain
41.39%

Cormorant Asset Management, LP's ARS Pharmaceuticals Inc Holding Summary

As of 2025-03-31, Cormorant Asset Management, LP held 1.60 Mil shares of ARS Pharmaceuticals Inc(SPRY), totaling $20.13 Mil. This investment constitutes 1.51% of their stock portfolio, and Cormorant Asset Management, LP now holds 1.63% of the outstanding ARS Pharmaceuticals Inc(SPRY) stock.

The initial trade took place in 2024Q4. And since then Cormorant Asset Management, LP has made 2 purchases of SPRY, at an average price of $12.65, for a total of 1.60 Mil shares. Based on historical transaction data and SPRY's current price of $17.88, Cormorant Asset Management, LP's estimated gain on his SPRY holdings is $8.38 Mil, reflecting a 41.39% gain to date.

Cormorant Asset Management, LP SPRY ($17.88) Holding Chart

Cormorant Asset Management, LP SPRY ($17.88) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1